| Name | Title | Contact Details |
|---|
Campbell County Hospital District, doing business as Campbell County Memorial Hospital, operates as a community hospital that provides healthcare services serving patients and residents in Gillette. The company offers emergency medical services, behavioral health services, cancer care, outpatient services, emergency care, home medical care, occupational health services, first aid and CPR services, OB GYN services, audiology, internal medicine, infectious disease care, neurology and pain care, geriatric medicine, nephrology, pulmonary and sleep medicine, urology, home care services, laboratory services, nutritional care, radiology, rehabilitation services, hospice care, ICU services, orthopedics and spine care, surgery, maternal child care, powder river surgery, nursing, and health sciences education programs, as well as ear, nose, and throat care. It also provides dialysis, medical and radiation oncology, daycare, and inpatient services; and patient channel services, including heart diseases and strokes care, pain management, diabetes, breastfeeding, general health and wellness, and other services. In addition, the company offers services in the areas of children's healthcare, diet/exercise programs, mental healthcare, senior healthcare, women's health, pregnancy, workplace healthcare, health assessments, and men's healthcare. Campbell County Hospital District was founded in 1981 and is based in Gillette, Wyoming.
Alquest has supported numerous international trials and registrations for device clients. Alquest's consulting staff comes from the medical device industry. We've been there. More than half our clients return to us for repeat business. Several device
Avery Manor is a Needham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
The RNS® System is an award-winning technology developed and manufactured in Silicon Valley that has been recognized for its innovation. Similar to a pacemaker that monitors and responds to heart rhythms, the RNS System is the world`s first and only medical device that can monitor and respond to brain activity. NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders with responsive stimulation. The company`s initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide.In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.